226907-85-3

Basic information

• Product Name: 9H-Purin-6-amine, 8-bromo-2-methoxy-9-(phenylmethyl)-
• CAS NO: 226907-85-3
• Molecular Formula: C13H12BrN5O
• Molecular Weight: 334.175
• Mol File: 226907-85-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 9H-Purin-6-amine, 8-bromo-2-methoxy-9-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 9H-Purin-6-amine, 8-bromo-2-methoxy-9-(phenylmethyl)-(226907-85-3)
• EPA Substance Registry System: 9H-Purin-6-amine, 8-bromo-2-methoxy-9-(phenylmethyl)-(226907-85-3)

Safety Data

• Hazardous Substances Data: 226907-85-3(Hazardous Substances Data)

Upstream product

• 56046-24-3 9-benzyl-2-methoxyadenine 
• 565473-06-5 5-amino-1-benzyl-2-bromo-1H-imidazole-4-carbonitrile 
• 60598-48-3 5-amino-1-benzyl-1H-imidazole-4-carbonitrile 
• 56046-25-4 6-amino-9-benzyl-2-chloropurine 
• 565473-07-6 9-benzyl-8-bromo-2-hydroxyadenine 

Downstream Products

• 226908-21-0 9-benzyl-2,8-dimethoxyadenine 
• 226908-41-4 9-benzyl-2,8-dihydroxyadenine 

Relevant articles and documents

Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilities

In order to create novel compounds which possess potent interferon (IFN) inducing activities with excellent oral bioavailabilities, a series of 8-hydroxyadenines, which have various alkoxy or alkylthio moieties at the adenine C(2)-position, were synthesiz

Heterocyclic compounds

The present invention relates to a heterocyclic compound of the following general formula (I): wherein X is sulfur atom, oxygen atom or —NR3— (R3may form a heterocyclic ring or a substituted heterocyclic ring with R1via the nitrogen atom), R1is alkyl group, substituted alkyl group, aryl group, substituted aryl group, heterocyclic group or substituted heterocyclic group, and R2is hydrogen atom, halogen atom etc.; or its pharmaceutically acceptable salt and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases comprising the compound (I) or its pharmaceutically acceptable salt as active ingredients.